🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Belgium
Clinical trial register · Belgium

Studies with a Belgian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3062 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:48 UTC
3062
Studies in scope
all four open statuses
1741
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Leuven 1265 Brussels 1116 Ghent 1043 Liège 564 Edegem 437
Narrow the register
Recruitment status
Phase
Lead sponsor
Universitaire Ziekenhuizen KU Leuven184 University Hospital, Ghent136 AstraZeneca102 Universitair Ziekenhuis Brussel82 Janssen Research & Development, LLC72
Site location
Leuven1265 Brussels1116 Ghent1043 Liège564 Edegem437
All 201 locations
Target enrolment
to

Trials in this register

3062 of 3062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Active, closed
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
NCT05361395Extensive Stage Small Cell Lung Cancer
DrugsTarlatamab·Etoposide·Atezolizumab·Durvalumab
Amgen
Phase 1
184
Edegem, Ghent, Hasselt, Roeselare
2022-08-24
Active, closed
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
NCT05399888Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
Biogen
Phase 2
416
Brussels, Kortrijk, Leuven
2022-08-24
Recruiting
Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity
NCT05165056Radiotherapy Side Effect, Vaginal Abnormality
Jessa Hospital
Not applicable
62
Genk, Hasselt
2022-08-24
Recruiting
Biomechanical and Morphological Characterization of PTTD
NCT06260813Posterior Tibial Tendon Dysfunction
Universitaire Ziekenhuizen KU Leuven
Not applicable
100
Leuven
2022-08-22
Recruiting
Multidisciplinary Approach to Fatigue
NCT05502224Breast Cancer, Germ Cell Tumor
Jules Bordet Institute
Not applicable
50
Brussels
2022-08-19
By invitation
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
NCT05374590Generalized Myasthenia Gravis, gMG
DrugsEfgartigimod PH20·Efgartigimod
argenx
Phase 2/3
12
Edegem, Ghent
2022-08-18
Active, closed
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
NCT05327530Locally Advanced or Metastatic Urothelial Carcinoma
DrugsAvelumab·Sacituzumab Govitecan
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Antwerp, Brasschaat, Brussels, Ghent, Kortrijk, Libramont, Liège, Wuerzburg
2022-08-17
Active, closed
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
NCT05524883Duchenne Muscular Dystrophy (DMD)
DrugZeleciment Rostudirsen
Dyne Therapeutics
Phase 1/2
86
Ghent, Leuven, Liège
2022-08-12
Active, closed
A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition
NCT05061134Melanoma
DrugsCeralasertib·Durvalumab
AstraZeneca
Phase 2
194
Belgium, Bruges, Ghent, Leuven
2022-08-11
Active, closed
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
NCT05330325SGA, Turner Syndrome, Noonan Syndrome, ISS
DrugsNorditropin·Somapacitan
Novo Nordisk A/S
Phase 3
412
Brussels, Edegem, Leuven
2022-08-10
Active, closed
The Belgian Endothelial Surgical Transplant of the Cornea
NCT05436665Corneal Edema, Corneal Endothelial Disorder, Fuchs' Endothelial Dystrophy, Bullous Keratopathy
University Hospital, Antwerp
Not applicable
220
Edegem, Ghent, Bruges, Bonheiden, Brussels, Deurne, Genk, Leuven
2022-08-10
Recruiting
Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome
NCT05492344ARDS, Human, Lung Ultrasound, Mechanical Ventilation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
538
Brussels
2022-08-09
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
Bonheiden, Brussels, La Louvière, Libramont, Yvoir, Aalst, Ghent, Kortrijk
2022-08-08
Active, closed
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
NCT05489237Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumor (GIST), Digestive System Disease, Gastrointestinal Diseases
DrugIDRX-42
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Phase 1
276
Leuven
2022-08-03
Recruiting
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259Ventilator Associated Pneumonia
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Observational
20,000
Brussels, Ghent, La Louvière, Liège, Ottignies-Louvain-la-Neuve
2022-08-03
Active, closed
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
NCT05261399Carcinoma, Non-Small-Cell Lung
DrugsSavolitinib·Tagrisso·Osimertinib·Pemetrexed
AstraZeneca
Phase 3
341
Brussels, Ghent, Roeselare
2022-08-03
Active, closed
Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis
NCT05297448Hepatic Encephalopathy
DrugRifaximin SSD
Bausch Health Americas, Inc.
Phase 3
466
Antwerp, Genk, Ghent, Kortrijk, Liège, Mechelen
2022-08-03
Recruiting
Timing of Soft Tissue Grafting Following Immediate Implant Placement
NCT05537545Bone Resorption
University Ghent
Not applicable
40
Ghent
2022-08-01
Recruiting
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
NCT05379595Advanced or Metastatic Colorectal Cancer
DrugsAmivantamab·Leucovorin·Fluorouracil·Irinotecan
Janssen Research & Development, LLC
Phase 1/2
225
Anderlecht, Brussels, Edegem, Leuven
2022-07-29
Recruiting
Biomechanical Investigation of Symptomatic FAI and Two Groups of Asymptomatic Controls
NCT06272292Femoroacetabular Impingement
Universitaire Ziekenhuizen KU Leuven
Not applicable
99
Leuven
2022-07-28
Active, closed
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
NCT05382286Triple Negative Breast Cancer, PD-L1 Positive
DrugsAbraxane·Taxol·Sacituzumab Govitecan·Nab-paclitaxel
Gilead Sciences
Phase 3
443
Anderlecht, Brasschaat, Brussels, Charleroi, Ghent, Leuven, Namur
2022-07-25
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
NCT05242471Crohn's Disease
DrugsJNJ-78934804·Golimumab·Guselkumab
Janssen Research & Development, LLC
Phase 2
703
Antwerp, Bruges, Brussels, Ghent, Leuven, Liège, Mechelen, Roeselare
2022-07-22
Recruiting
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
NCT05491200ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy
Research Maatschap Cardiologen Rotterdam Zuid
Phase 4
1,656
Bonheiden, Bruges, Genk, Leuven, Roeselare
2022-07-22
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Leuven, Sint-Niklaas
2022-07-22
Active, closed
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
NCT05371613Mucopolysaccharidosis II
DrugsIdursulfase·Tividenofusp alfa
Denali Therapeutics Inc.
Phase 2/3
65
Antwerp, Jette
2022-07-21
Active, closed
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
NCT05382299Triple Negative Breast Cancer, PD-L1 Negative
DrugsAbraxane·Sacituzumab Govitecan·Nab-paclitaxel·Gemcitabine
Gilead Sciences
Phase 3
623
Brasschaat, Brussels, Charleroi, Ghent, Leuven, Namur
2022-07-20
Recruiting
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
NCT05413850Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC, Urogenital Neoplasms
Blue Earth Therapeutics Ltd
Phase 1/2
82
Brussels, Ghent, Leuven
2022-07-20
Active, closed
Assess Safety and Efficacy of VAD044 in HHT Patients
NCT05406362Hereditary Hemorrhagic Telangiectasia (HHT)
Vaderis Therapeutics AG
Phase 1/2
75
Ghent
2022-07-18
Active, closed
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
NCT05296798Locally Advanced or Metastatic Breast Cancer
DrugsPhesgo·Giredestrant·Docetaxel·Paclitaxel
Hoffmann-La Roche
Phase 3
922
Charleroi, Ghent, Hasselt, Leuven, Namur
2022-07-18
Active, closed
The TRICURE First in Human Trial
NCT05126030Tricuspid Regurgitation
TRiCares
Not applicable
20
Aalst, Antwerp, Brussels, Liège
2022-07-15
Recruiting
Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia
NCT05506332Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
DrugsMercaptopurine·Venetoclax
University Hospital, Antwerp
Phase 1
10
Edegem, Roeselare
2022-07-15
Recruiting
Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven
NCT05000723Prosthetic Joint Infection, Hip Prosthesis Infection
Universitaire Ziekenhuizen KU Leuven
Observational
50
Leuven
2022-07-14
Active, closed
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
NCT05352672Melanoma
DrugsFianlimab·Cemiplimab·Pembrolizumab
Regeneron Pharmaceuticals
Phase 3
1,546
Kortrijk, Sint-Niklaas, Brussels, Namur
2022-07-14
Recruiting
Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy
NCT05667857Cognitive Remediation, Neuropsychology, Quality of Life, Psycho-Oncology
Universitair Ziekenhuis Brussel
Not applicable
100
Brussels
2022-07-13
Active, closed
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
NCT05392114Hereditary Angioedema
DrugDonidalorsen
Ionis Pharmaceuticals, Inc.
Phase 3
154
Edegem
2022-07-13
Active, closed
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
NCT05217446Metastatic Colorectal Cancer
DrugsEncorafenib·Erbitux·Cetuximab·Keytruda
Pfizer
Phase 2
108
Bonheiden, Anderlecht, Brussels
2022-07-11
Active, closed
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
NCT05360446Coronary Artery Disease
DrugInclisiran sodium
Novartis Pharmaceuticals
Phase 3
609
Turnhout, Genk, Hasselt, Yvoir, Aalst
2022-07-08
Active, closed
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
NCT05338970Nonsquamous Non-small Cell Lung Cancer, EGFR L858R, EGFR Exon 19 Deletion
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 3
586
Brussels, Leuven, Mechelen, Roeselare
2022-07-08
Active, closed
A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy
NCT05337553Spinal Muscular Atrophy, Neuromuscular Diseases, SMA
DrugTaldefgrobep alfa
Biohaven Pharmaceuticals, Inc.
Phase 3
269
Edegem, Ghent, Leuven
2022-07-06
Active, closed
Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
NCT05267613Erosive Esophagitis
DrugNexium
AstraZeneca
Phase 3
53
Namur
2022-07-01
Active, closed
Laparoscopic Inguinal and Femoral heRniA rePaIr Using Pre-shapeD 4DMESH® (4DLap)
NCT05306496Inguinal Hernia, Femoral Hernia
Cousin Biotech
Not applicable
196
Genk, Tienen, Kortrijk
2022-06-30
Active, closed
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
NCT05257408Ovarian Neoplasm, Fallopian Tube Neoplasms, Peritoneal Neoplasms
DrugsNab-paclitaxel /m^2·Relacorilant
Corcept Therapeutics
Phase 3
381
Aalst, Brussels, Charleroi, Hasselt, Leuven, Liège
2022-06-29
Recruiting
International Wilson's Disease Patient Registry (iWilson Registry)
NCT05239858Wilson's Disease
Orphalan
Observational
500
Leuven
2022-06-29
Recruiting
Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium
NCT06714149Pollen Allergy
prof. dr. Rik Schrijvers
Not applicable
200
Leuven
2022-06-29
Active, closed
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
NCT05281328Polycystic Liver Disease
DrugCAM2029
Camurus AB
Phase 2/3
71
Leuven
2022-06-28
Active, closed
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
NCT05186753SSM, Mastocytosis, Indolent, Mastocytosis, Systemic, Mastocytosis
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
237
Edegem, La Louvière
2022-06-27
Active, closed
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997Multiple Myeloma
DrugsIberdomide·Bortezomib·Daratumumab·Dexamethasone
Celgene
Phase 3
939
Bruges, Brussels
2022-06-23
Recruiting
Lymphedema After Gyneco-oncologic Treatment
NCT05469945Lymphedema, Genital Neoplasm
University Hospital, Ghent
Not applicable
218
Ghent, Leuven
2022-06-22
Active, closed
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
NCT04970901B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma
DrugsLoncastuximab Tesirine·Mosunetuzumab·Polatuzumab Vedotin·Glofitamab
ADC Therapeutics S.A.
Phase 1
154
Ghent, Yvoir
2022-06-17
Recruiting
Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies
NCT05611515Supraglottic Squamous Cell Carcinoma, Early Stage (T1-T2, N0-N1,M0)
Centre Hospitalier Universitaire UCLouvain Namur
Observational
108
Yvoir
2022-06-17
Recruiting
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
NCT05433142Clear Cell Renal Cell Carcinoma
Xencor, Inc.
Phase 1
307
Leuven
2022-06-13
Active, closed
Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.
NCT05293002Peripheral Arterial Disease
ID3 Medical
Not applicable
131
Antwerp, Hasselt, Liège, Ghent, Sint-Niklaas, Bruges, Aalst, Bonheiden
2022-06-13
Active, closed
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
NCT05348733Chronic Kidney Disease, Type 2 Diabetes Mellitus
DrugKerendia
Bayer
Observational
4,613
Multiple Locations
2022-06-13
By invitation
A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
NCT05352919Systemic Lupus Erythematosus (SLE)
DrugLitifilimab
Biogen
Phase 3
864
Liège
2022-06-10
Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
NCT05384626Locally Advanced Solid Tumor, Metastatic Solid Tumor
DrugsNeladalkib·Repaglinide·Itraconazole·Midazolam
Nuvalent Inc.
Phase 1/2
840
Antwerp, Leuven
2022-06-09
Recruiting
Evaluation of Medication Tapering on the Sensitivity of the Spinal Cord Using Closed-Loop Spinal Cord Stimulation (Pilot Study)
NCT07502612Failed Back Surgery Syndrome (FBSS), Persistent Spinal Pain Syndrome Type 2 (PSPS-T) Lower Spine, Neurophysiological Sensitivity to Spinal Cord Stimulation
Brai²n
Observational
20
Wilrijk
2022-06-08
Recruiting
Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.
NCT05550675Double Incontinence, Faecal Incontinence, Urinary Incontinence
Universitair Ziekenhuis Brussel
Observational
150
Brussels
2022-06-08
Recruiting
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
NCT05477589Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation
Vastra Gotaland Region
Phase 3
170
Brussels, Ghent, Leuven, Liège
2022-06-07
Active, closed
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
NCT05115110Spinal Muscular Atrophy (SMA)
DrugsRO7204239·Risdiplam
Hoffmann-La Roche
Phase 2/3
97
Ghent, Liège
2022-06-02
Recruiting
Titanium Reinforced d-PTFE Membrane Versus Collagen Membrane For Guided Bone Regeneration
NCT05426616Alveolar Ridge Enlargement
University Ghent
Not applicable
36
Ghent, Zottegem, Zwijnaarde
2022-06-01
Active, closed
A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy
NCT04808206Obesity, Roux-en-Y Gastric Bypass, Gastrostomy, Nissen Sleeve
Duomed
Observational
150
Genk, Haine-Saint-Paul, Maaseik
2022-06-01
Active, closed
HEAL-IST IDE Trial
NCT05280093Inappropriate Sinus Tachycardia
AtriCure, Inc.
Not applicable
142
Brussels
2022-05-31
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
NCT05076175Colitis, Ulcerative
DrugOzanimod
Bristol-Myers Squibb
Phase 2/3
120
Brussels, Leuven, Edegem, Liège
2022-05-30
Recruiting
PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.
NCT06059469TNBC - Triple-Negative Breast Cancer
Jules Bordet Institute
Phase 2
20
Brussels
2022-05-30
Recruiting
Parental Support Intervention in an Advanced Oncological Context
NCT07341815Metastatic Cancer, Cancer Recurrence, Hematological Cancer, Parent-Child Relations
Université Libre de Bruxelles
Not applicable
120
Anderlecht
2022-05-27
Recruiting
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes
NCT06770621Severe Hypoglycemia, Type1diabetes
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Not applicable
1,000
Brussels
2022-05-25
Recruiting
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
NCT05472259Metastatic Pancreatic Ductal Adenocarcinoma
DrugsNanoliposomal Irinotecan·5-FU·Leucovorin·Fluorouracil
Belgian Group of Digestive Oncology
Phase 2
134
Antwerp, Brussels, Liège, Bruges, Bonheiden, Charleroi, Ghent, Haine-Saint-Paul
2022-05-25
Active, closed
Added Value of Cognitive Behavioural Therapy for Insomnia in Persons With Knee Osteoarthritis
NCT05387473Osteoarthritis, Knee, Insomnia
Vrije Universiteit Brussel
Not applicable
128
Leuven
2022-05-25
Active, closed
Ankyloglossia and Its Effects on Breastfeeding, Feeding and Speech Disorders. A Prospective Study From Birth to 4 Years of Age.
NCT07512765Ankyloglossia, Breastfeeding, Breastfeeding Self-Efficacy, Breastfeeding Duration
Erasme University Hospital
Observational
348
Brussels
2022-05-23
Recruiting
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
NCT05304377Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Cml
DrugELVN-001
Enliven Therapeutics
Phase 1
250
Ghent, Leuven, Liège
2022-05-22
Active, closed
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)
NCT05123703Relapsing-remitting Multiple Sclerosis
DrugsFingolimod·Ocrelizumab
Hoffmann-La Roche
Phase 3
188
Ghent
2022-05-19
Active, closed
IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)
NCT05155254Metastatic Melanoma, Unresectable Melanoma
DrugsIO102-IO103·Pembrolizumab
IO Biotech
Phase 3
407
Ghent, Sint-Niklaas
2022-05-17
Active, closed
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
NCT05374512Breast Cancer
DrugsEribulin·Datopotamab Deruxtecan·Nab-paclitaxel·Capecitabine
AstraZeneca
Phase 3
644
Anderlecht, Ghent, Namur, Sint-Niklaas, Wilrijk
2022-05-16
Recruiting
Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients
NCT07087964Newly Diagnosed Multiple Myeloma (NDMM)
Universiteit Antwerpen
Observational
120
Antwerp, Ghent, Leuven, Bruges
2022-05-16
Recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
NCT05307705Breast Cancer
DrugsAnastrozole, Exemestane·Imlunestrant·Abemaciclib·Letrozole
Eli Lilly and Company
Phase 1
260
Anderlecht, Leuven
2022-05-11
Recruiting
Return to Work for Persistent Spinal Pain Syndrome Type II Patients
NCT05269212Failed Back Surgery Syndrome, Spinal Cord Stimulation
Moens Maarten
Not applicable
112
Ghent, Hasselt, Jette, Sint-Niklaas, Turnhout
2022-05-10
Recruiting
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
NCT05179876Hypertension, Pulmonary
DrugsMacitentan·Selexipag
Actelion
Phase 3
280
Leuven
2022-05-04
Active, closed
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
NCT05269004Multiple Sclerosis
DrugOcrelizumab
Hoffmann-La Roche
Phase 3
1,300
Bruges, Brussels, Edegem, Eeklo, Roeselare
2022-05-03
Active, closed
Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations
NCT05315414Jaw, Edentulous, Partially
Dentsply Sirona Implants and Consumables
Not applicable
138
Leuven
2022-05-03
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
NCT04879329Urothelial Carcinoma
DrugsDisitamab Vedotin·Keytruda·Pembrolizumab
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Ghent, Namur
2022-05-03
Recruiting
A Multicenter Retrospective Analysis of Postoperative Respiratory Complications in Children With Obstructive Sleepapnea
NCT07305168Obstructive Sleep Apnea, Postoperative Respiratory Complications, Adenotonsillectomy, Child Obesity
University Hospital, Antwerp
Observational
200
Edegem
2022-05-02
Active, closed
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
NCT05270044Melanoma
Pierre Fabre Medicament
Phase 3
815
Anderlecht, Antwerp, Brussels, Ghent, Merksem, Sint-Niklaas, Yvoir
2022-05-02
Recruiting
Evaluation of the Safety and Efficacy of the ReLARC Inserter During the Insertion Procedure of GYNEFIX Intrauterine Copper Bearing Contraceptive Device With a Follow-up of 3 Years.
NCT05702281Contraception
University Hospital, Ghent
Not applicable
120
Ghent
2022-05-01
Recruiting
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648Esophageal Cancer, Radiotherapy, Side Effect, Proton Therapy
University of Aarhus
Phase 3
396
Leuven
2022-05-01
Recruiting
Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease
NCT05309863Pediatric Non-alcoholic Fatty Liver Disease
University Hospital, Ghent
Observational
850
Ghent, De Haan
2022-05-01
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Liège
2022-04-27
Active, closed
Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease
NCT05192616Angioplasty, Peripheral Arterial Disease, Iliac Artery Disease, Covered Stent
iVascular S.L.U.
Observational
241
Aalst, Bonheiden, Dendermonde, Genk
2022-04-27
Recruiting
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
NCT05344235Prostate Cancer, Radiotherapy, SBRT
Universitaire Ziekenhuizen KU Leuven
Observational
246
Leuven
2022-04-25
Recruiting
Changes in Body Fat and Morphologic Characteristics Associated With OSA Resolution After Bariatric Surgery
NCT05315752Obesity, Obstructive Sleep Apnea
Centre Hospitalier Universitaire Saint Pierre
Observational
60
Brussels
2022-04-22
Recruiting
Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
NCT05114850Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency, Heart Failure
P+F Products + Features GmbH
Observational
450
Aalst
2022-04-20
Recruiting
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
NCT05352178Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic, Metastatic Cancer
Universitaire Ziekenhuizen KU Leuven
Phase 3
873
Leuven
2022-04-20
By invitation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
NCT05303532Cancer
DrugDurvalumab
AstraZeneca
Phase 3
214
Charleroi
2022-04-19
Recruiting
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
NCT04916613Prostate Cancer Metastatic
DrugDarolutamide
UNICANCER
Phase 3
300
Charleroi, Haine-Saint-Paul, Namur, Ottignies
2022-04-19
Recruiting
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT04685616Hodgkin Lymphoma
DrugsVinblastine·Bleomycin·Brentuximab Vedotin·Dacarbazine
University College, London
Phase 3
1,042
Roeselare, Antwerp, Leuven, Namur
2022-04-14
Active, closed
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
NCT05288166Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs
DrugsAbiraterone·Prednisolone·Abemaciclib·Prednisone
Eli Lilly and Company
Phase 3
925
Aalst, Ghent, Kortrijk, Namur
2022-04-14
Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
NCT05061550Non-small Cell Lung Cancer
DrugsAZD0171·Pemetrexed/Cisplatin·Pemetrexed/Carboplatin·Monalizumab
AstraZeneca
Phase 2
630
Ghent, Roeselare
2022-04-14
Active, closed
Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients
NCT05074810Non Small Cell Lung Cancer, KRAS Activating Mutation
DrugLumakras
Verastem, Inc.
Phase 1/2
153
Ghent, Liège
2022-04-12
Recruiting
Prospective Image Collection of Colorectal Polyps.
NCT07401264Colonic Lesions
Universitaire Ziekenhuizen KU Leuven
Observational
5,000
Leuven
2022-04-07
Recruiting
Bio Impedance Monitoring as a Tool to Assess Fluid Status in the Pediatric Surgical Patient? (PedFluid Study)
NCT05220709Fluid and Electrolyte Imbalance, Body Weight Changes, Children, Only
University Hospital, Antwerp
Not applicable
100
Edegem
2022-04-05
By invitation
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
NCT05248659Immunoglobulin A Nephropathy
DrugSibeprenlimab
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Genk
2022-04-05
Rows per page Showing 2001–2100 of 3062
Previous 19 20 21 22 23 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-belgium?page=21

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,062 studies in total at the last sync on 26 Sep 2026, 19:48 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Belgium?

1,741 of the 3,062 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:48 UTC sync. A further 147 have not yet opened recruitment, 1,075 are active but closed to new participants, and 99 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (61) Multiple Myeloma (35) Prostate Cancer (27) Ulcerative Colitis (27) Ovarian Cancer (25) Obesity (25) Heart Failure (25) Crohn's Disease (25) Stroke (24) Cancer (24) Multiple Sclerosis (23) Non-small Cell Lung Cancer (23) Non-Small Cell Lung Cancer (22) Healthy (22) Atrial Fibrillation (22)
→

Browse trials by site location

Leuven (1265) Brussels (1116) Ghent (1043) Liège (564) Edegem (437) Antwerp (292) Bruges (264) Roeselare (250) Hasselt (215) Aalst (193) Kortrijk (184) Genk (175) Charleroi (174) Anderlecht (165) Yvoir (153)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.